Status:

COMPLETED

Assessment of Nociceptive Processing Among Patients With Temporo-mandibular Disorders

Lead Sponsor:

Université Catholique de Louvain

Conditions:

Temporomandibular Disorder

Eligibility:

FEMALE

18-50 years

Phase:

NA

Brief Summary

This case control study will investigate the physiological effect of nociceptive input in individuals with temporomandibular disorders. To do so, the investigators will compare the development of seco...

Detailed Description

This control study is designed to compare the development of secondary hyperalgesia following high frequency electrical stimulation (HFS) of skin nociceptors in the forearms in individuals with chroni...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for healthy controls:
  • Females aged between 18 and 50 years.
  • BMI between 17 and 30.
  • Ability to provide written informed consent.
  • Exclusion Criteria for healthy controls:
  • Evidence of psychiatric/inflammatory/neurological or metabolic comorbidities on direct questioning as this study is meant to focus on musculoskeletal disorders.
  • Evidence of skin alteration on the volar forearms that may interfere with HFS.
  • Any substance abuse, or the use of antidepressant or neuroleptic medication as these may interfere with the psychophysical examination.
  • Any painful musculoskeletal disorder.
  • Lack of dental check-ups during the last 12 months.
  • Inclusion Criteria for the TMD group:
  • Females aged between 18 and 50 years.
  • BMI between 17 and 30.
  • Ability to provide written informed consent.
  • Chronic TMD (for at least 3 months) as a main complain (according to the DC/TMD), with an average of at least 3/10 on a pain numerical rating scale during the past month in the orofacial region.
  • Exclusion Criteria for the TMD group:
  • Evidence of psychiatric/inflammatory/neurological or metabolic comorbidities on direct questioning as this study is meant to focus on musculoskeletal disorders.
  • Evidence of skin alteration on the volar forearms that may interfere with HFS.
  • Any substance abuse, or the use of antidepressant or neuroleptic medication as these may interfere with the psychophysical examination.
  • Lack of dental check-ups during the last 12 months

Exclusion

    Key Trial Info

    Start Date :

    January 11 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    March 29 2022

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT04086732

    Start Date

    January 11 2021

    End Date

    March 29 2022

    Last Update

    April 7 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Cliniques universitaires St-Luc

    Brussels, Belgium, 1200